Stance Capital LLC Makes New $2.01 Million Investment in Mettler-Toledo International, Inc. $MTD

Stance Capital LLC acquired a new stake in Mettler-Toledo International, Inc. (NYSE:MTD) in the second quarter, Holdings Channel.com reports. The firm acquired 1,713 shares of the medical instruments supplier’s stock, valued at approximately $2,012,000.

Several other institutional investors also recently modified their holdings of the stock. WPG Advisers LLC purchased a new position in shares of Mettler-Toledo International in the 1st quarter worth about $41,000. NewSquare Capital LLC boosted its position in Mettler-Toledo International by 94.4% during the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 17 shares during the period. MV Capital Management Inc. lifted its position in Mettler-Toledo International by 50.0% in the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 12 shares during the last quarter. State of Wyoming bought a new stake in Mettler-Toledo International in the 2nd quarter worth $58,000. Finally, Sound Income Strategies LLC lifted its holdings in Mettler-Toledo International by 477.8% in the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 43 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider La Guerroniere Marc De sold 6,055 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total transaction of $9,010,929.90. Following the transaction, the insider directly owned 187 shares of the company’s stock, valued at $278,289.66. This trade represents a 97.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Elisha W. Finney sold 474 shares of the company’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total value of $679,512.18. Following the transaction, the director directly owned 311 shares in the company, valued at approximately $445,840.27. The trade was a 60.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 19,565 shares of company stock worth $28,683,737 over the last three months. 1.94% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

MTD has been the topic of several research reports. Barclays lifted their price target on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research report on Monday, November 10th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 8th. Morgan Stanley started coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price target for the company. The Goldman Sachs Group assumed coverage on Mettler-Toledo International in a research note on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 target price on the stock. Finally, Bank of America boosted their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Five investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $1,424.17.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,394.97 on Friday. The business’s fifty day moving average is $1,402.13 and its 200 day moving average is $1,292.98. The company has a market capitalization of $28.50 billion, a PE ratio of 34.79, a price-to-earnings-growth ratio of 4.50 and a beta of 1.40. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The firm’s revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.